Spoken Alpha · Executive
Glenn Pierce
Interim CSOatVYGRVoyager Therapeutics, Inc. In our data from Jun 3, 2021
Tracked across 1 earnings call in our data since 2022.
Our data window: 2020–present. Actual tenure for some executives extends earlier — see company bio for full history.
Research tier
See how this executive's language deviates from their own baseline
Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.